Posttreatment liver function, but not baseline liver function stratifies patient survival after direct-acting antiviral treatment in decompensated cirrhosis with hepatitis C virus

Short-term hepatocyte function and portal hypertension outcomes of sofosbuvir/velpatasvir for decompensated hepatitis C-related cirrhosis

(2023) Kohei Kotani et al.   JOURNAL OF GASTROENTEROLOGY

Clinical outcomes after treatment with direct antiviral agents: beyond the virological response in patients with previous HCV-related decompensated cirrhosis

(2022) Georges-Philippe Pageaux et al.   BMC INFECTIOUS DISEASES

Liver-related events after direct-acting antiviral therapy in patients with hepatitis C virus-associated cirrhosis

(2022) Yuki Tahata et al.   JOURNAL OF GASTROENTEROLOGY

Long-term survival and clinical outcomes following direct-acting antiviral (DAA) treatment in HCV decompensated cirrhosis in Brazil: a real-world study

(2022) Gustavo H. Pereira et al.   Brazilian Journal of Infectious Diseases

A combination of hepatic encephalopathy and body mass index was associated with the point of no return for improving liver functional reserve after sofosbuvir/velpatasvir treatment in patients with hepatitis C virus‐related decompensated cirrhosis

(2022) Tomoya Sano et al.   HEPATOLOGY RESEARCH

Early‐phase prothrombin time‐international normalized ratio in acute liver injury indicates the timing of therapeutic intervention and predicts prognostic improvement

(2022) Kotaro Kumagai et al.   HEPATOLOGY RESEARCH

Effect of sofosbuvir and velpatasvir therapy on clinical outcome in hepatitis C virus patients with decompensated cirrhosis

(2022) Yuki Tahata et al.   HEPATOLOGY RESEARCH

Clinical course of hepatitis C virus‐positive patients with decompensated liver cirrhosis in the era of direct‐acting antiviral treatment

(2021) Kazuki Maesaka et al.   HEPATOLOGY RESEARCH

Mortality rates and risk factors in 1412 Japanese patients with decompensated hepatitis C virus-related cirrhosis: a retrospective long-term cohort study

(2021) Shunichiro Fujiyama et al.   BMC GASTROENTEROLOGY

Evidence‐based clinical practice guidelines for liver cirrhosis 2020

(2021) Hitoshi Yoshiji et al.   HEPATOLOGY RESEARCH

Prognosis of patients with liver cirrhosis: A multi‐center retrospective observational study

(2021) Hayato Yamana et al.   HEPATOLOGY RESEARCH

Evidence-based clinical practice guidelines for Liver Cirrhosis 2020

(2021) Hitoshi Yoshiji et al.   JOURNAL OF GASTROENTEROLOGY

Time‐course changes in liver functional reserve after successful sofosbuvir/velpatasvir treatment in patients with decompensated cirrhosis

(2021) Masanori Atsukawa et al.   HEPATOLOGY RESEARCH

Japan Society of Hepatology guidelines for the management of hepatitis C virus infection: 2019 update

(2020)   HEPATOLOGY RESEARCH

Real‐world efficacy and safety of 12‐week sofosbuvir/velpatasvir treatment for patients with decompensated liver cirrhosis caused by hepatitis C virus infection

(2020) Yoshinari Takaoka et al.   HEPATOLOGY RESEARCH

Sofosbuvir plus velpatasvir treatment for hepatitis C virus in patients with decompensated cirrhosis: a Japanese real-world multicenter study

(2020) Yuki Tahata et al.   JOURNAL OF GASTROENTEROLOGY

Clinical outcomes following DAA therapy in patients with HCV-related cirrhosis depend on disease severity

(2020) Lisette A.P. Krassenburg et al.   JOURNAL OF HEPATOLOGY

The REDCap consortium: Building an international community of software platform partners

(2019) Paul A. Harris et al.   JOURNAL OF BIOMEDICAL INFORMATICS

Efficacy and safety of sofosbuvir–velpatasvir with or without ribavirin in HCV-infected Japanese patients with decompensated cirrhosis: an open-label phase 3 trial

(2018) Tetsuo Takehara et al.   JOURNAL OF GASTROENTEROLOGY

Treatment with direct-acting antivirals improves the clinical outcome in patients with HCV-related decompensated cirrhosis: results from an Italian real-life cohort (Liver Network Activity—LINA cohort)

(2018) Ivan Gentile et al.   Hepatology International

Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study Of Liver Diseases and the European Association for the Study of the Liver

(2014) Hendrik Vilstrup et al.   HEPATOLOGY

Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics support

(2008) Paul A. Harris et al.   JOURNAL OF BIOMEDICAL INFORMATICS